Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Oct 2020 10:59 AM
EQS
Oxford Biomedica (OXB): Vector innovation key t...
02 Oct 2020 11:52 AM
RNS
Total Voting Rights
29 Sep 2020 03:51 PM
RNS
Director Dealings
24 Sep 2020 09:36 AM
RNS
Director/PDMR Shareholding
22 Sep 2020 12:54 PM
RNS
Director/PDMR Shareholding
17 Sep 2020 07:00 AM
RNS
Interim Results
01 Sep 2020 09:33 AM
RNS
Total Voting Rights
01 Sep 2020 07:00 AM
RNS
Master Supply and Development Agreement with AZ
27 Aug 2020 07:00 AM
RNS
Notice of Interim Results
25 Aug 2020 04:46 PM
RNS
Block listing Application
03 Aug 2020 09:41 AM
RNS
Total Voting Rights
03 Aug 2020 07:00 AM
RNS
OXB signs DMLA with Beam Therapeutics
31 Jul 2020 07:00 AM
RNS
OXB Signs Clinical Supply Agreement with Axovant
20 Jul 2020 04:23 PM
RNS
OXB notes interim results from AZ on AZD1222
03 Jul 2020 10:45 AM
RNS
Director Dealings / Market Share Purchase
02 Jul 2020 03:39 PM
RNS
Director Dealings / Market Share Purchase
02 Jul 2020 01:34 PM
RNS
Director Dealings / Market Share Transactions
01 Jul 2020 06:30 PM
RNS
Holdings in Company
01 Jul 2020 03:44 PM
RNS
Block listing Return
01 Jul 2020 09:13 AM
RNS
Total Voting Rights
30 Jun 2020 03:23 PM
RNS
Grant of options
25 Jun 2020 09:44 AM
RNS
Holding(s) in Company
24 Jun 2020 11:45 AM
RNS
Holdings in Company
24 Jun 2020 09:54 AM
RNS
Director Dealings / Share Disposal - Replacement
24 Jun 2020 07:00 AM
RNS
Director Dealings / Market Share Purchase
23 Jun 2020 04:46 PM
RNS
Result of Annual General Meeting
23 Jun 2020 02:47 PM
RNS
Admission of shares and Total Voting Rights.
23 Jun 2020 07:00 AM
RNS
Annual General Meeting
19 Jun 2020 03:26 PM
RNS
Information in Relation to Annual General Meeting
19 Jun 2020 07:00 AM
RNS
Result of Placing
18 Jun 2020 05:33 PM
RNS
Proposed Placing of new Ordinary Shares
08 Jun 2020 04:01 PM
RNS
Update on Sanofi Ophthalmology Programmes
08 Jun 2020 07:00 AM
RNS
Five Year Collaboration Agreement signed with VMIC
01 Jun 2020 09:06 AM
RNS
Total Voting Rights
01 Jun 2020 07:00 AM
RNS
Dr Roch Doliveux appointed Non-Executive Chairman
28 May 2020 12:16 PM
RNS
Clinical & Commercial Supply Agreement with AZ
27 May 2020 11:26 AM
RNS
Director Dealings / Market Share Purchase
22 May 2020 05:28 PM
RNS
2019 Annual report and Accounts & AGM Notification
20 May 2020 02:34 PM
RNS
Holding(s) in Company
13 May 2020 06:02 PM
RNS
Holding(s) in Company
13 May 2020 07:00 AM
RNS
OXB receives approval for first two Oxbox suites
11 May 2020 04:25 PM
RNS
PDMR Dealings / Market Share sale
06 May 2020 12:36 PM
RNS
Directors Dealings / Market Share Purchases
06 May 2020 07:00 AM
RNS
Preliminary Results
01 May 2020 09:05 AM
RNS
Total Voting Rights
28 Apr 2020 01:04 PM
RNS
Compliance with LR 9.2.6ER(1)
24 Apr 2020 11:48 AM
RNS
Director/PDMR Shareholding
23 Apr 2020 08:38 AM
RNS
Holding(s) in Company
22 Apr 2020 12:03 PM
RNS
Kymriah receives FDA RMAT designation in FL
20 Apr 2020 04:49 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings